Kisqali

(ribociclib)
NO BOXED WARNING

Dosage & Administration

KISQALI tablets are taken orally with or without food in combination with an aromatase inhibitor or fulvestrant.

Early Breast Cancer

Advanced or Metastatic Breast Cancer


Dose interruption, reduction, and/or discontinuation may be required based on individual safety and tolerability.

Get Your Patient on Kisqali

See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Or select your Insurance from the list below:

Kisqali Prescribing Information

Kisqali Prior Authorization Resources

Most recent state uniform prior authorization forms

Kisqali PubMed™ News